QDEL Key Statistics, Chart & Performance
The current stock price of QDEL is 27.28 USD. In the past month the price decreased by -6.89%. In the past year, price decreased by -37.23%.
QDEL Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to QDEL. When comparing the yearly performance of all stocks, QDEL is a bad performer in the overall market: 84.69% of all stocks are doing better.
QDEL Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to QDEL. QDEL has a bad profitability rating. Also its financial health evaluation is rather negative.
QDEL Financial Highlights
Over the last trailing twelve months QDEL reported a non-GAAP Earnings per Share(EPS) of 2.29. The EPS decreased by -4.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -20.78% | ||
| ROE | -57.9% | ||
| Debt/Equity | 1.23 |
QDEL Forecast & Estimates
14 analysts have analysed QDEL and the average price target is 37.59 USD. This implies a price increase of 37.81% is expected in the next year compared to the current price of 27.28.
For the next year, analysts expect an EPS growth of 17.21% and a revenue growth -2.44% for QDEL
QDEL Ownership
About QDEL
Company Profile
QuidelOrtho Corp. operates as a vitro diagnostics company. The company is headquartered in San Diego, California and currently employs 6,600 full-time employees. The firm specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. The company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
Company Info
QUIDELORTHO CORP
9975 Summers Ridge Road
San Diego CALIFORNIA 92121 US
CEO: Douglas C. Bryant
Employees: 6600
Phone: 18585521100
QUIDELORTHO CORP / QDEL FAQ
Can you describe the business of QUIDELORTHO CORP?
QuidelOrtho Corp. operates as a vitro diagnostics company. The company is headquartered in San Diego, California and currently employs 6,600 full-time employees. The firm specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. The company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
What is the current price of QDEL stock?
The current stock price of QDEL is 27.28 USD. The price decreased by -4.88% in the last trading session.
Does QDEL stock pay dividends?
QDEL does not pay a dividend.
What is the ChartMill rating of QUIDELORTHO CORP stock?
QDEL has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Is QUIDELORTHO CORP (QDEL) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on QDEL.
What is the market capitalization of QDEL stock?
QUIDELORTHO CORP (QDEL) has a market capitalization of 1.85B USD. This makes QDEL a Small Cap stock.
What is the next earnings date for QDEL stock?
QUIDELORTHO CORP (QDEL) will report earnings on 2026-02-11, after the market close.